These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34018710)

  • 1. mRNA fingerprint of early-stage clear cell renal cell carcinoma identified in urinary exosomes by mRNA sequencing.
    Marek-Bukowiec K; Konieczny A; Ratajczyk K; Czapor-Irzabek H; Górniak A; Kowal P
    Pol Arch Intern Med; 2021 Jun; 131(6):582-585. PubMed ID: 34018710
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.
    Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B
    J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.
    Kurahashi R; Kadomatsu T; Baba M; Hara C; Itoh H; Miyata K; Endo M; Morinaga J; Terada K; Araki K; Eto M; Schmidt LS; Kamba T; Linehan WM; Oike Y
    Cancer Sci; 2019 Jun; 110(6):1897-1908. PubMed ID: 31006167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
    Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
    Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.
    Liu Y; Fu W; Cao X; Li S; Xiong T; Zhang X; Wu X; Cheng L; Wei Y; Gao B
    Comput Math Methods Med; 2021; 2021():5517747. PubMed ID: 34122615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
    Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K
    Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment.
    Wang C; He Y; Zheng J; Wang X; Chen S
    Front Immunol; 2023; 14():1130513. PubMed ID: 37153569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of exosomes-related lncRNAs in clear cell renal cell carcinoma based on Bayesian spike-and-slab lasso approach.
    Niu Y; Jia X; Wang N; Yuan M; Dong A; Yang Y; Shi X
    Funct Integr Genomics; 2023 Feb; 23(1):62. PubMed ID: 36805328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential protein profiling of renal cell carcinoma urinary exosomes.
    Raimondo F; Morosi L; Corbetta S; Chinello C; Brambilla P; Della Mina P; Villa A; Albo G; Battaglia C; Bosari S; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1220-33. PubMed ID: 23511837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormalities of anti-oncogene p53 in renal cell carcinoma].
    Li M; Gu FL; Li WB
    Zhonghua Wai Ke Za Zhi; 1994 Aug; 32(8):487-9. PubMed ID: 7882775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of Pax-2 mRNA in renal cell carcinoma tissue and parenchyma of the affected kidney.
    Igarashi T; Ueda T; Suzuki H; Tobe T; Komiya A; Ichikawa T; Ito H
    Int J Urol; 2001 Feb; 8(2):60-4. PubMed ID: 11240827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.
    Zhuang Q; Qian X; Cao Y; Fan M; Xu X; He X
    J Int Med Res; 2014 Apr; 42(2):282-91. PubMed ID: 24514433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
    Tölle A; Suhail S; Jung M; Jung K; Stephan C
    BMC Cancer; 2011 Jul; 11():302. PubMed ID: 21767383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of SSX2 gene in human urologic neoplasms].
    Du P; Yu LZ; Ma M; Geng L; Wang XS; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):379-81. PubMed ID: 15854347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
    Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.
    Xia Y; Zhang Q; Zhen Q; Zhao Y; Liu N; Li T; Hao Y; Zhang Y; Luo C; Wu X
    Oncotarget; 2017 Jun; 8(23):37783-37795. PubMed ID: 28384121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas.
    Kitagawa Y; Kunimi K; Uchibayashi T; Sato H; Namiki M
    J Urol; 1999 Sep; 162(3 Pt 1):905-9. PubMed ID: 10458406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
    Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.